Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 7;50(2):178–190. doi: 10.1111/1440-1681.13740

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Clinical and Experimental Pharmacology and Physiology published by John Wiley & Sons Australia, Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Kaplan–Meier curves for progression‐free survival (PFS) and overall survival (OS) comparing patients with advanced non‐small cell lung cancer (NSCLC) patients who received death protein‐1 (PD‐1) inhibitor combined with chemotherapy as first‐line according to variances of inflammatory/nutritional indexes. (A, F) PFS and OS stratified by the baseline neutrophil‐to‐lymphocyte ratio (NLR) index, (B, G) PFS and OS stratified by the baseline platelet‐to‐lymphocyte ratio (PLR) index, (C, H) PFS and OS stratified by the baseline systemic immune‐inflammation index (SII) index, (D, I) PFS and OS stratified by the baseline prognostic nutritional index (PNI) index, (E, J) PFS and OS stratified by the baseline haemoglobin, albumin, lymphocyte and platelet (HALP) index.